Search research articles
Contact Us
Filters
Showing results (41-50 of 505) with videos related to
Page
of 51
Sort By:
Frontiers in Immunology
|
December 2, 2024
Editorial: Basic, clinical, and translational studies of Yao syndrome and other NOD2 related diseases
John M Davis, Christine McDonald, Qingping Yao
The American Journal of Psychiatry
|
November 5, 2013
Increasing placebo response in antipsychotic drug trials: let's stop the vicious circle
Stefan Leucht, Stephan Heres, John M Davis
Seminars in Arthritis and Rheumatism
|
November 28, 2015
Indirect comparisons of the efficacy of biological agents in patients with psoriatic arthritis with an inadequate response to traditional disease-modifying anti-rheumatic drugs or to non-steroidal anti-inflammatory drugs: A meta-analysis
Patompong Ungprasert, Charat Thongprayoon, John M Davis
Clinical Rheumatology
|
February 8, 2016
Indirect comparisons of the efficacy of subsequent biological agents in patients with psoriatic arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis
Patompong Ungprasert, Charat Thongprayoon, John M Davis
Plos One
|
June 22, 2017
Factors associated with successful transition among children with disabilities in eight European countries
John Ravenscroft, Kerri Wazny, John M Davis
Psychological Medicine
|
January 9, 2020
Antipsychotic drugs: from 'major tranquilizers' to Neuroscience-based-Nomenclature
Spyridon Siafis, John M Davis, Stefan Leucht
JAMA Psychiatry
|
November 24, 2021
Limitations in Research on Maintenance Treatment for Individuals With Schizophrenia-Reply
Stefan Leucht, Spyridon Siafis, John M Davis
European Archives of Psychiatry and Clinical Neuroscience
|
September 29, 2021
Should 'typical', first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
Stefan Leucht, Maximilian Huhn, John M Davis
Archives of General Psychiatry
|
June 11, 2003
A meta-analysis of the efficacy of second-generation antipsychotics
John M Davis, Nancy Chen, Ira D Glick
The Journal of Clinical Psychiatry
|
September 13, 2006
Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia
Ira D Glick, Diana Pham, John M Davis
Page
of 51
Search research articles
Search
Showing results (41-50 of 505) with videos related to
Sort By:
Page
of 51
Frontiers in Immunology
|
December 2, 2024
Editorial: Basic, clinical, and translational studies of Yao syndrome and other NOD2 related diseases
John M Davis, Christine McDonald, Qingping Yao
The American Journal of Psychiatry
|
November 5, 2013
Increasing placebo response in antipsychotic drug trials: let's stop the vicious circle
Stefan Leucht, Stephan Heres, John M Davis
Seminars in Arthritis and Rheumatism
|
November 28, 2015
Indirect comparisons of the efficacy of biological agents in patients with psoriatic arthritis with an inadequate response to traditional disease-modifying anti-rheumatic drugs or to non-steroidal anti-inflammatory drugs: A meta-analysis
Patompong Ungprasert, Charat Thongprayoon, John M Davis
Clinical Rheumatology
|
February 8, 2016
Indirect comparisons of the efficacy of subsequent biological agents in patients with psoriatic arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis
Patompong Ungprasert, Charat Thongprayoon, John M Davis
Plos One
|
June 22, 2017
Factors associated with successful transition among children with disabilities in eight European countries
John Ravenscroft, Kerri Wazny, John M Davis
Psychological Medicine
|
January 9, 2020
Antipsychotic drugs: from 'major tranquilizers' to Neuroscience-based-Nomenclature
Spyridon Siafis, John M Davis, Stefan Leucht
JAMA Psychiatry
|
November 24, 2021
Limitations in Research on Maintenance Treatment for Individuals With Schizophrenia-Reply
Stefan Leucht, Spyridon Siafis, John M Davis
European Archives of Psychiatry and Clinical Neuroscience
|
September 29, 2021
Should 'typical', first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
Stefan Leucht, Maximilian Huhn, John M Davis
Archives of General Psychiatry
|
June 11, 2003
A meta-analysis of the efficacy of second-generation antipsychotics
John M Davis, Nancy Chen, Ira D Glick
The Journal of Clinical Psychiatry
|
September 13, 2006
Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia
Ira D Glick, Diana Pham, John M Davis
Page
of 51